A Tumor‐Targeting Metal‐Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade. Issue 3 (5th November 2021)

• Record Type: Journal Article
• Authors: Liu, Tianya; Yan, Jin; He, Chenchen; You, Weiming; Ma, Fang; Chang, Zhuo; Li, Yong; Han, Suxia; He, Wangxiao; Liu, Wenjia
• Is Part Of: Small. Volume 18:Issue 3(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-11-05
• Subjects: cancer therapy -- infinite coordination polymers -- peptide -- tumor immunotherapy -- tumor targeting; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.202104849
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract: Targeted and immunological therapy have revolutionized the malignancy treatment, but is suffering from the dose‐limiting side effects and inadequate responsiveness. The emerging nanoscale infinite coordination polymers provide a feasible strategy for tumor targeting and immune sensitization. Herein, a "one‐pot" self‐assembled strategy based on dynamic combinatorial chemistry (DCC) principle is designed to construct a tumor‐targeting metal‐organic nanoparticle (MOICP) through a spontaneous co‐assembling among three metal‐organic coordination polymers tuned by a Wnt‐inhibitor carnosic acid (CA). Responding to the tumor microenvironment, MOICP presents an optimized tumor‐preferential accumulation and the satisfactory biosafety. MOICP is more active in vitro and in vivo than CA in suppressing of Wnt signaling pathway, and potently inhibits tumor growth in a patient‐derived xenograft model of Wnt‐activated pancreatic carcinoma. Moreover, MOICP reverses the lack of intratumoral infiltration of T lymphocytes, and hence augments the action of Anti‐PD1 (programmed cell death protein 1) immunotherapy in B16F10 melanoma allograft mice model. This clinically viable MOICP can not only be applied to Wnt inhibition for cancer targeted therapy and immunotherapeutic sensitization, but also provides a de novo pattern for nanomedicine architecture with cargo‐initiated co‐self‐assembly guided by DCC, thereby bringing new inspiration in general for disease intervention. Abstract : A "one‐pot" self‐assembled strategy based on dynamic combinatorial chemistry principle is designed to construct a tumor‐targeting metal‐organic nanoparticle (MOICP) through a spontaneous co‐assembling among three metal‐organic coordination polymers tuned by a Wnt‐inhibitor carnosic acid. Responding to the acidic and hypoxic tumor microenvironment, MOICP presents an optimized tumor‐preferential accumulation and the satisfactory biosafety.